Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction

Arthur J Moss1, Daniel Ryan, David Oakes

  • 1Cardiology Unit, Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. heartajm@heart.rochester.edu

Insights

Carrying more atherosclerotic risk genotypes was unexpectedly associated with a lower risk of recurrent coronary events. This suggests a potential population-level risk reversal phenomenon in post-infarction patients.

Area of Science:

  • Cardiovascular Genetics
  • Epidemiology
  • Genetics

Background:

  • Atherosclerotic risk genotypes are typically associated with increased coronary event risk.
  • Previous studies show inconsistent associations between genetic risk factors and cardiovascular outcomes.

Purpose of the Study:

  • To investigate the association between prespecified atherosclerotic risk genotypes and recurrent coronary events in post-myocardial infarction patients.
  • To evaluate the average risk associated with carrying these genotypes using a carrier-ship approach.

Main Methods:

  • Cohort study of 1,008 post-infarction patients with an average follow-up of 28 months.
  • Time-dependent survivorship analysis to assess genotype risk.
  • Adjustment for genetic, clinical, and environmental covariates.

Main Results:

  • A hazard ratio of 0.89 (p=0.03) indicated an 11% average reduction in recurrent coronary event risk per carried genotype.
  • Cumulative event probability at 1 year decreased with increasing number of carried genotypes (13% for >=5 genotypes vs. 26% for <=1 genotype).

Conclusions:

  • An unexpected risk reversal phenomenon was observed, where carrying more risk genotypes correlated with lower recurrent event rates.
  • This finding may explain inconsistent genetic risk factor associations in prior coronary population studies.
  • Population-based risk factor dynamics might underlie this observed phenomenon.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...